0
     

Report Added
Report already added
Dynamics in Post-pandemic Global Fragment-based Drug Discovery Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Fragment-based Drug Discovery Industry: Supply and Demand, Markets and Prices 2021-2027

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Fragment-based Drug Discovery market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Fragment-based Drug Discovery market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Fragment Screening
Fragment Optimization

Segmented by End User/Segment
Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Sygnature Discovery
Structure Based Design
Sprint Bioscience
Proteros Fragments
Kinetic Discovery
Evotec
Emerald BioStructures
Crown Bioscience
Charles River Laboratories
Beactica
Astex Pharmaceuticals
Alveus Pharmaceuticals

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Fragment-based Drug Discovery Market Status and Forecast (2016-2027)
1.3.2 Global Fragment-based Drug Discovery Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Fragment-based Drug Discovery Supply by Company
2.1 Global Fragment-based Drug Discovery Sales Value by Company
2.2 Fragment-based Drug Discovery Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Fragment-based Drug Discovery Market Status by Category
3.1 Fragment-based Drug Discovery Category Introduction
3.1.1 Fragment Screening
3.1.2 Fragment Optimization
3.2 Global Fragment-based Drug Discovery Market by Category
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Fragment-based Drug Discovery Market Status by End User/Segment
4.1 Fragment-based Drug Discovery Segment by End User/Segment
4.1.1 Academic and Research Institutions
4.1.2 Biopharmaceutical Companies
4.1.3 Contract Research Organizations (CROs)
4.2 Global Fragment-based Drug Discovery Market by End User/Segment
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Fragment-based Drug Discovery Market Status by Region
5.1 Global Fragment-based Drug Discovery Market by Region
5.2 North America Fragment-based Drug Discovery Market Status
5.3 Europe Fragment-based Drug Discovery Market Status
5.4 Asia Pacific Fragment-based Drug Discovery Market Status
5.5 Central & South America Fragment-based Drug Discovery Market Status
5.6 Middle East & Africa Fragment-based Drug Discovery Market Status
6 North America Fragment-based Drug Discovery Market Status
6.1 North America Fragment-based Drug Discovery Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Fragment-based Drug Discovery Market Status
7.1 Europe Fragment-based Drug Discovery Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Fragment-based Drug Discovery Market Status
8.1 Asia Pacific Fragment-based Drug Discovery Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Fragment-based Drug Discovery Market Status
9.1 Central & South America Fragment-based Drug Discovery Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Fragment-based Drug Discovery Market Status
10.1 Middle East & Africa Fragment-based Drug Discovery Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Fragment-based Drug Discovery Market Forecast by Category and by End User/Segment
12.1 Global Fragment-based Drug Discovery Sales Value Forecast (2022-2027)
12.2 Global Fragment-based Drug Discovery Forecast by Category
12.3 Global Fragment-based Drug Discovery Forecast by End User/Segment
13 Global Fragment-based Drug Discovery Market Forecast by Region/Country
13.1 Global Fragment-based Drug Discovery Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Sygnature Discovery
14.1.1 Company Information
14.1.2 Fragment-based Drug Discovery Product Introduction
14.1.3 Sygnature Discovery Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Structure Based Design
14.2.1 Company Information
14.2.2 Fragment-based Drug Discovery Product Introduction
14.2.3 Structure Based Design Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Sprint Bioscience
14.3.1 Company Information
14.3.2 Fragment-based Drug Discovery Product Introduction
14.3.3 Sprint Bioscience Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Proteros Fragments
14.4.1 Company Information
14.4.2 Fragment-based Drug Discovery Product Introduction
14.4.3 Proteros Fragments Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Kinetic Discovery
14.5.1 Company Information
14.5.2 Fragment-based Drug Discovery Product Introduction
14.5.3 Kinetic Discovery Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Evotec
14.6.1 Company Information
14.6.2 Fragment-based Drug Discovery Product Introduction
14.6.3 Evotec Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Emerald BioStructures
14.7.1 Company Information
14.7.2 Fragment-based Drug Discovery Product Introduction
14.7.3 Emerald BioStructures Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Crown Bioscience
14.8.1 Company Information
14.8.2 Fragment-based Drug Discovery Product Introduction
14.8.3 Crown Bioscience Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Charles River Laboratories
14.9.1 Company Information
14.9.2 Fragment-based Drug Discovery Product Introduction
14.9.3 Charles River Laboratories Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Beactica
14.10.1 Company Information
14.10.2 Fragment-based Drug Discovery Product Introduction
14.10.3 Beactica Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Astex Pharmaceuticals
14.12 Alveus Pharmaceuticals
15 Conclusion
16 MethodologyList of Tables

Table Global Fragment-based Drug Discovery Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Fragment-based Drug Discovery Sales Value (Million USD) by Company (2019-2021)
Table Global Fragment-based Drug Discovery Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Fragment-based Drug Discovery Sales Area
Table Fragment-based Drug Discovery Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Fragment-based Drug Discovery Sales Value (Million USD) by Category (2016-2021)
Table Global Fragment-based Drug Discovery Sals Value Market Share by Category (2016-2021)
Table North America Fragment-based Drug Discovery Sales Value (Million USD) by Category (2016-2021)
Table North America Fragment-based Drug Discovery Sales Value Market Share by Category (2016-2021)
Table Europe Fragment-based Drug Discovery Sales Value (Million USD) by Category (2016-2021)
Table Europe Fragment-based Drug Discovery Sales Value Market Share by Category (2016-2021)
Table Asia Pacific Fragment-based Drug Discovery Sales Value (Million USD) by Category (2016-2021)
Table Asia Pacific Fragment-based Drug Discovery Sales Value Market Share by Category (2016-2021)
Table Central & South America Fragment-based Drug Discovery Sales Value (Million USD) by Category (2016-2021)
Table Central & South America Pacific Fragment-based Drug Discovery Sales Value Market Share by Category (2016-2021)
Table Middle East & Africa Fragment-based Drug Discovery Sales Value (Million USD) by Category (2016-2021)
Table Middle East & Africa Fragment-based Drug Discovery Sales Value Market Share by Category (2016-2021)
Table Global Fragment-based Drug Discovery Sales Value (Million USD) by End User/Segment (2016-2021)
Table Global Fragment-based Drug Discovery Value Market Share by End User/Segment (2016-2021)
Table North America Fragment-based Drug Discovery Sales Value (Million USD) by End User/Segment (2016-2021)
Table North America Fragment-based Drug Discovery Sales Value Market Share by End User/Segment (2016-2021)
Table Europe Fragment-based Drug Discovery Sales Value (Million USD) by End User/Segment (2016-2021)
Table Europe Fragment-based Drug Discovery Sales Value Market Share by End User/Segment (2016-2021)
Table Asia Pacific Fragment-based Drug Discovery Sales Value (Million USD) by End User/Segment (2016-2021)
Table Asia Pacific Fragment-based Drug Discovery Sales Value Market Share by End User/Segment (2016-2021)
Table Central & South America Fragment-based Drug Discovery Sales Value (Million USD) by End User/Segment (2016-2021)
Table Central & South America Pacific Fragment-based Drug Discovery Sales Value Market Share by End User/Segment (2016-2021)
Table Middle East & Africa Fragment-based Drug Discovery Sales Value (Million USD) by End User/Segment (2016-2021)
Table Middle East & Africa Fragment-based Drug Discovery Sales Value Market Share by End User/Segment (2016-2021)
Table Global Fragment-based Drug Discovery Sales Value (Million USD) by Region (2016-2021)
Table Global Fragment-based Drug Discovery Value Market Share by Region (2016-2021)
Table North America Fragment-based Drug Discovery Sales Value (Million USD) by Country (2016-2021)
Table North America Fragment-based Drug Discovery Value Market Share by Country (2016-2021)
Table Europe Fragment-based Drug Discovery Sales Value (Million USD) by Country (2016-2021)
Table Europe Fragment-based Drug Discovery Value Market Share by Country (2016-2021)
Table Asia Pacific Fragment-based Drug Discovery Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Fragment-based Drug Discovery Value Market Share by Country (2016-2021)
Table Central & South America Fragment-based Drug Discovery Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Fragment-based Drug Discovery Value Market Share by Country (2016-2021)
Table Middle East & Africa Fragment-based Drug Discovery Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Fragment-based Drug Discovery Value Market Share by Country (2016-2021)
Table Global Fragment-based Drug Discovery Value (Million USD) Forecast by Category (2022-2027)
Table Global Fragment-based Drug Discovery Value Market Share Forecast by Category (2022-2027)
Table Global Fragment-based Drug Discovery Value (Million USD) Forecast by End User/Segment (2022-2027)
Table Global Fragment-based Drug Discovery Value Market Share Forecast by End User/Segment (2022-2027)
Table Global Fragment-based Drug Discovery Value (Million USD) Forecast by Region (2022-2027)
Table Global Fragment-based Drug Discovery Value Market Share Forecast by Region (2022-2027)
Table Sygnature Discovery Company Information
Table Sygnature Discovery Product Introduction
Table Sygnature Discovery Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
Table Structure Based Design Company Information
Table Structure Based Design Product Introduction
Table Structure Based Design Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
Table Sprint Bioscience Company Information
Table Sprint Bioscience Product Introduction
Table Sprint Bioscience Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
Table Proteros Fragments Company Information
Table Proteros Fragments Product Introduction
Table Proteros Fragments Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
Table Kinetic Discovery Company Information
Table Kinetic Discovery Product Introduction
Table Kinetic Discovery Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
Table Evotec Company Information
Table Evotec Product Introduction
Table Evotec Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
Table Emerald BioStructures Company Information
Table Emerald BioStructures Product Introduction
Table Emerald BioStructures Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
Table Crown Bioscience Company Information
Table Crown Bioscience Product Introduction
Table Crown Bioscience Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
Table Charles River Laboratories Company Information
Table Charles River Laboratories Product Introduction
Table Charles River Laboratories Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)
Table Beactica Company Information
Table Beactica Product Introduction
Table Beactica Fragment-based Drug Discovery Sales Value, Gross Margin and Global Share (2019-2021)

Kindly Fill The Form Below

Report Title: Dynamics in Post-pandemic Global Fragment-based Drug Discovery Industry: Supply and Demand, Markets and Prices 2021-2027


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW